Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
sector : N::A tags : Therapeutics save search
Allarity Therapeutics Receives NASDAQ-Approved Extension to Regain Compliance with Nasdaq Listing Rule 5550(b)(1)
Published: 2024-04-17 (Crawled : 13:00) - globenewswire.com
ALLR | News | $1.505 -10.42% -11.63% 1.1M
|
n/a
|
| O: -9.52%
H: 0.0%
C: 0.0%
nasdaq extension therapeutics
Zevra Therapeutics Presents New Data on the Long-Term Safety and Efficacy of Arimoclomol as a Treatment for Niemann-Pick Disease Type C at the SIMD 45th Annual Meeting
Published: 2024-04-15 (Crawled : 21:00) - globenewswire.com
ZVRA | $4.66 -2.31% -2.36% 210K
|
n/a
|
| O: 1.15%
H: 1.03%
C: -1.45%
disease treatment for meeting therapeutics
Zevra Therapeutics Refinances Existing Debt with up to $100M in Committed Capital under New Credit Facility
Published: 2024-04-10 (Crawled : 12:00) - globenewswire.com
ZVRA | $4.66 -2.31% -2.36% 210K
|
n/a
|
| O: -0.42%
H: 6.74%
C: 3.58%
therapeutics
Allarity Therapeutics Announces 1-for-20 Reverse Stock Split
Published: 2024-04-04 (Crawled : 13:00) - globenewswire.com
ALLR | News | $1.505 -10.42% -11.63% 1.1M
|
n/a
|
| O: 10.2%
H: 7.41%
C: -8.52%
therapeutics
Addex and Perceptive Launch Neurosterix with $63 Million to Accelerate Development of Allosteric Modulator Therapeutics for Neurological Disorders
Published: 2024-04-03 (Crawled : 05:00) - globenewswire.com
ADXN | $22.8 0.89% 0.88% 16K
|
Health Technology
|
| O: 14.12%
H: 15.82%
C: 1.95%
million disorders neurological therapeutics
Zevra Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Updates
Published: 2024-03-28 (Crawled : 21:00) - globenewswire.com
ZVRA | $4.66 -2.31% -2.36% 210K
|
n/a
| Email alert
Add to watchlist
year therapeutics financial results
Allarity Therapeutics Makes Strategic Pivot to Focus Solely on Accelerating Stenoparib Toward Regulatory Approval in Advanced Recurrent Ovarian Cancer
Published: 2024-03-27 (Crawled : 12:30) - globenewswire.com
ALLR | News | $1.505 -10.42% -11.63% 1.1M
|
n/a
|
| O: 0.32%
H: 2.87%
C: 2.87%
approval cancer therapeutics advanced
Zevra Therapeutics Announces Top-Line Data from the Phase 2 Clinical Trial of KP1077 for Idiopathic Hypersomnia
Published: 2024-03-26 (Crawled : 21:00) - globenewswire.com
ZVRA | $4.66 -2.31% -2.36% 210K
|
n/a
|
| O: 1.22%
H: 3.11%
C: 2.59%
kp1077 trial therapeutics
Zevra Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference
Published: 2024-03-25 (Crawled : 21:00) - globenewswire.com
ZVRA | $4.66 -2.31% -2.36% 210K
|
n/a
|
| O: 1.42%
H: 2.1%
C: 0.0%
conference therapeutics
Allarity Therapeutics Receives Extension from Nasdaq Hearings Panel to Regain Compliance with Listing Rules 5550(a)(2) and 5550(b)(1)
Published: 2024-03-25 (Crawled : 12:00) - globenewswire.com
ALLR | News | $1.505 -10.42% -11.63% 1.1M
|
n/a
|
| O: -0.28%
H: 2.18%
C: -12.0%
nasdaq extension therapeutics
Relief Therapeutics Enters into Exclusive U.S. License and Supply Agreement with Eton Pharmaceuticals for PKU GOLIKE
Published: 2024-03-22 (Crawled : 08:00) - biospace.com/
RLFTF | $1.35 11.45% 3.5K
|
n/a
|
| O: -3.07%
H: 18.31%
C: 12.54%
ETON | $3.13 -1.88% -1.92% 95K
|
Health Technology
|
| O: 6.08%
H: 5.73%
C: 3.13%
license pharmaceuticals golike therapeutics agreement
Delisting of Securities of Latch, Inc.; Eloxx Pharmaceuticals, Inc.; Collective Audience, Inc. (f.k.a., ABRIC SPAC I); SeqLL Inc.; Nemaura Medical Inc.; LumiraDx Limited; Cemtrex Inc.; COMSovereign Holding Corp.; Global System Dynamics; Arrival; Nubia Brand International Corp.; The Alkaline Water Company Inc.; DMK Pharmaceuticals Corporation; MedAvail Holdings, Inc.; InVivo Therapeutics Holdings Corp.; and ADDvantage Technologies Group, Inc. from The Nasdaq Stock Market
Published: 2024-03-20 (Crawled : 20:00) - globenewswire.com
COMS | News | $0.2 37.35% 3.4K
|
Manufacturing
|
| O: -2.27%
H: 27.46%
C: 15.87%
WTER | $0.01 14185.71% 11K
|
Consumer Non-Durables
|
| O: 0.0%
H: 614.29%
C: 0.0%
NDAQ | News | $60.01 -0.03% -0.03% 2.8M
|
Finance
|
| O: 0.46%
H: 3.09%
C: 1.11%
CETX | $3.09 -3.44% -3.56% 12K
|
Electronic Technology
|
| O: 0.22%
H: 1.85%
C: -2.22%
water company international spac pharmaceuticals global system medical therapeutics market
Bristol Myers Squibb Completes Acquisition of PureTech's Founded Entity Karuna Therapeutics for $14 Billion
Published: 2024-03-18 (Crawled : 15:30) - biospace.com/
BMY | $47.84 -0.87% -0.02% 12M
|
Health Technology
|
| O: 0.46%
H: 0.23%
C: -1.88%
acquisition therapeutics
Zevra Therapeutics to Report 2023 Fourth Quarter and Full Year Financial Results on March 28, 2024
Published: 2024-03-18 (Crawled : 12:00) - globenewswire.com
ZVRA | $4.66 -2.31% -2.36% 210K
|
n/a
|
| O: 0.67%
H: 0.33%
C: -1.32%
report year therapeutics financial results
Tryp Therapeutics Announces 99.92% Votes Cast by Shareholders in Favor of Arrangement Agreement at Annual General and Special Meeting of Securityholders, and Receipt of Final Order
Published: 2024-03-12 (Crawled : 11:00) - biospace.com/
CYBN | $0.3754 -1.11% -0.91% 2M
|
n/a
|
| O: -5.59%
H: 18.53%
C: 16.8%
meeting order therapeutics agreement
Structure Therapeutics to Present at Leerink Partners Global Biopharma Conference
Published: 2024-03-08 (Crawled : 21:00) - globenewswire.com
GPCR | $36.99 -2.2% -2.24% 590K
|
n/a
| Email alert
Add to watchlist
conference biopharma global therapeutics
Structure Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Highlights
Published: 2024-03-08 (Crawled : 13:30) - globenewswire.com
GPCR | $36.99 -2.2% -2.24% 590K
|
n/a
|
| O: 2.17%
H: 7.37%
C: 0.19%
year therapeutics financial results
Allarity Therapeutics Reports Full Year 2023 Financial Results and Provides a Business Update
Published: 2024-03-08 (Crawled : 12:30) - globenewswire.com
ALLR | News | $1.505 -10.42% -11.63% 1.1M
|
n/a
|
| O: 2.65%
H: 0.0%
C: -3.23%
business year update therapeutics financial results
Human Microbiome Therapeutics Market size to grow by USD 732.95 million from 2022 to 2027, North America to account for 41% of market growth, Technavio
Published: 2024-03-06 (Crawled : 15:30) - prnewswire.com
PTCHF | $2.78 19.97% 560
|
n/a
|
| O: 4.12%
H: 0.97%
C: 0.97%
FNCH | $2.5 -19.36% -24.0% 130K
|
Professional, Scientific, and T...
|
| O: -4.0%
H: 4.92%
C: 4.12%
EVGN | $0.7 -13.64% 63K
|
Health Technology
|
| O: 4.24%
H: 0.0%
C: -7.14%
PHGE | $0.2801 -0.07% 0.0% 130K
|
Health Technology
|
| O: 211.55%
H: 18.75%
C: -4.46%
america million therapeutics market
Zevra Therapeutics Provides FDA Update on the PDUFA Action Date for Arimoclomol as a Treatment for Niemann-Pick Disease Type C
Published: 2024-03-04 (Crawled : 12:30) - globenewswire.com
ZVRA | $4.66 -2.31% -2.36% 210K
|
n/a
|
| O: -5.79%
H: 0.15%
C: -6.75%
fda disease update treatment pdufa therapeutics
Gainers vs Losers
| 56% | 44% |
Top 10 Gainers
INVO | $1.76 131.58% 56.82% 230M
|
Health Technology
SINT | $0.0365 59.39% 37.26% 470M
|
Health Technology
WISA 4 | $9.19 50.66% 33.7% 65M
|
Electronic Technology
EDBL | News | $6.73 47.91% 32.39% 13M
|
GCTK | $0.715 36.27% 26.62% 640K
|
Manufacturing
TCON | $2.33 36.26% 26.61% 2M
|
Health Technology
TIRX | $0.48 6.43% 24.58% 4.8M
|
KZIA | $0.38 30.58% 23.42% 300K
|
Health Technology
VNDA | News | $5.23 29.14% 22.56% 24M
|
Health Technology
ATNF | $1.91 29.05% 22.51% 310K
|
Your saved searches
Save your searches and get alerts when important news are released.